U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001
  1. Regulatory Information

GUIDANCE DOCUMENT

Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001 Guidance for Industry February 2001

Final

Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001

Docket Number:
98D-0545
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research

This guidance document provides the recommendations of the Food and Drug Administration (FDA) for the use of FDA cleared automated blood cell separators in blood establishments for collecting single and double units of Red Blood Cells (RBC). This guidance also describes the information to be included in a license application or supplement. This final guidance document finalizes the draft guidance document entitled “Guidance for Industry: Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods, dated July 1998.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: 98D-0545.

Questions?

Contact Point
Office of Communication, Outreach and Development (OCOD)
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3128
Silver Spring, MD 20993-0002
ocod@fda.hhs.gov
(800) 835-4709
(240) 402-8010